Vitamin D receptor (VDR) localization in human promyelocytic leukemia cells

References

• Brown A J, Dusso A S, Slatopolsky E. Vitamin D analogues for secondary hyperparathyroidism. Nephrology Dialysis Transplants 2002; 17: 10–19
   PubMed Web of Science ®Google Scholar
• Wu-Wong J R, Tian J, Goltzman D. Vitamin D analogs as therapeutic agents: a clinical study update. Current Opinions in Investigative Drugs 2004; 5: 320–326
   PubMedGoogle Scholar
• Carlberg C, Quack M, Herdick M, Bury Y, Polly P, Toell A. Central role of VDR conformations for understanding selective actions of vitamin D(3) analogues. Steroids 2001; 66: 213–221
   PubMed Web of Science ®Google Scholar
• Slatopolsky E, Brown A, Dusso A. Pathogenesis of secondary hyperparathyroidism. Kidney International Supplement 1999; 73: S14–S19
   PubMedGoogle Scholar
• Ritz E, Stefanski A, Rambausek M. The role of the parathyroid glands in the uremic syndrome. American Journal of Kidney Disease 1995; 26: 808–813
   PubMed Web of Science ®Google Scholar
• Martin K J, Gonzalez E A. Vitamin D analogs: actions and role in the treatment of secondary hyperparathyroidism. Seminars in Nephrology 2004; 24: 456–459
   PubMed Web of Science ®Google Scholar
• Hanchette C L, Schwartz G G. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 1992; 70: 2861–2869
   PubMed Web of Science ®Google Scholar
• Banerjee P, Chatterjee M. Antiproliferative role of vitamin D and its analogs—a brief overview. Molecular Cell Biochemistry 2003; 253: 247–254
   PubMed Web of Science ®Google Scholar
• Albertson D G, Ylstra B, Segraves R, Collins C, Dairkee S H, Kowbel D, et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Natural Genetics 2000; 25: 144–146
   PubMed Web of Science ®Google Scholar
• Bortman P, Folgueira M A, Katayama M L, Snitcovsky I M, Brentani M M. Antiproliferative effects of 1,25-dihydroxyvitamin D3 on breast cells: a mini review. Brazilian Journal of Medical Biology Research 2002; 35: 1–9
   PubMed Web of Science ®Google Scholar
• Shabahang M, Buras R R, Davoodi F, Schumaker L M, Nauta R J, Evans S R. 1,25-Dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition. Cancer Research 1993; 53: 3712–3718
   PubMed Web of Science ®Google Scholar
• Mimori K, Tanaka Y, Yoshinaga K, Masuda T, Yamashita K, Okamoto M, et al. Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer. Annals of Oncology 2004; 15: 236–241
   PubMed Web of Science ®Google Scholar
• James S Y, Williams M A, Newland A C, Colston K W. Leukemia cell differentiation: cellular and molecular interactions of retinoids and vitamin D. General Pharmacology 1999; 32: 143–154
   PubMedGoogle Scholar
• Brumbaugh P F, Haussler M R. 1 Alpha,25-dihydroxycholecalciferol receptors in intestine. II. Temperature-dependent transfer of the hormone to chromatin via a specific cytosol receptor. Journal of Biological Chemistry 1974; 249: 1258–1262
   PubMed Web of Science ®Google Scholar
• Balmain N, Hauchecorne M, Pike J W, Cuisinier-Gleizes P, Mathieu H. Distribution and subcellular immunolocalization of 1,25-dihydroxyvitamin D3 receptors in rat epiphyseal cartilage. Cellular & Molecular Biology (Noisy-le-grand) 1993; 39: 339–350
   PubMed Web of Science ®Google Scholar
• Barsony J, Renyi I, McKoy W. Subcellular distribution of normal and mutant vitamin D receptors in living cells. Studies with a novel fluorescent ligand. Journal of Biological Chemistry 1997; 272: 5774–5782
   Google Scholar
• Babidge W, Millard S, Roediger W. Sulfides impair short chain fatty acid beta-oxidation at acyl-CoA dehydrogenase level in colonocytes: implications for ulcerative colitis. Molecular Cell Biochemistry 1998; 181: 117–124
   PubMed Web of Science ®Google Scholar
• Htun H, Barsony J, Renyi I, Gould D L, Hager G L. Visualization of glucocorticoid receptor translocation and intranuclear organization in living cells with a green fluorescent protein chimera. Proceedings of the National Academy of Sciences (USA) 1996; 93: 4845–4850
   PubMed Web of Science ®Google Scholar
• Huhtakangas J A, Olivera C J, Bishop J E, Zanello L P, Norman A W. The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha,25(OH)2-vitamin D3 in vivo and in vitro. Molecular Endocrinology 2004; 18: 2660–2671, Epub 2004 Jul 2622
   PubMed Web of Science ®Google Scholar
• Solvsten H, Svendsen M L, Fogh K, Kragballe K. Upregulation of vitamin D receptor levels by 1,25(OH)2 vitamin D3 in cultured human keratinocytes. Archives of Dermatology Research 1997; 289: 367–372
   PubMed Web of Science ®Google Scholar
• Hulla W, Kallay E, Krugluger W, Peterlik M, Cross H S. Growth control of human colon-adenocarcinoma-derived Caco-2 cells by vitamin-D compounds and extracellular calcium in vitro: relation to c-myc-oncogene and vitamin-D-receptor expression. International Journal of Cancer 1995; 62: 711–716
   PubMed Web of Science ®Google Scholar
• Taoka T, Collins E D, Irino S, Norman A W. 1,25(OH)2-vitamin D3 mediated changes in mRNA for c-myc and 1,25(OH)2D3 receptor in HL-60 cells and related subclones. Molecular Cell Endocrinology 1993; 95: 51–57
   PubMed Web of Science ®Google Scholar
• Schwartz G G, Whitlatch L W, Chen T C, Lokeshwar B L, Holick M F. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiology Biomarkers Previews 1998; 7: 391–395
   PubMed Web of Science ®Google Scholar
• Barreto A M, Schwartz G G, Woodruff R, Cramer S D. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. Cancer Epidemiology Biomarkers Previews 2000; 9: 265–270
   PubMed Web of Science ®Google Scholar
• Martin K J, Gonzalez E A, Gellens M E, Hamm L L, Abboud H, Lindberg J. Therapy of secondary hyperparathyroidism with 19-nor-1alpha,25-dihydroxyvitamin D2. American Journal of Kidney Disease 1998; 32: S61–S66
   PubMed Web of Science ®Google Scholar
• Kumagai T, O'Kelly J, Said J W, Koeffler H P. Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activity against leukemia, myeloma, and colon cancer cells. Journal of the National Cancer Institute 2003; 95: 896–905
   PubMed Web of Science ®Google Scholar